Angiotensin II receptor blockers in heart failure. - Wikidata - wikimedia - TriplyDB

Angiotensin II receptor blockers in heart failure.

Angiotensin II receptor blockers in heart failure.

http://www.wikidata.org/entity/Q35066800

about

Valsartan for the treatment of heart failure.Recent advances in the secondary prevention of coronary heart disease.The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.

P2860

Q35609704-045CAA60-ED03-421C-8E1C-B503BCA550B4 Q35925701-2ACCEAFA-DA46-404A-8415-0B794BC0E1EA Q42694416-13C05391-6CEA-4B78-BF77-A9F0A0BA17CC

P2860

Angiotensin II receptor blockers in heart failure.

http://www.wikidata.org/entity/Q35066800

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Angiotensin II receptor blockers in heart failure.

@ast

Angiotensin II receptor blockers in heart failure.

@en

type

label

Angiotensin II receptor blockers in heart failure.

@ast

Angiotensin II receptor blockers in heart failure.

@en

prefLabel

Angiotensin II receptor blockers in heart failure.

@ast

Angiotensin II receptor blockers in heart failure.

@en

P1433

Q35066800-DEC450ED-00F5-4820-83C1-C6F6F172EFB3

P1476

Q35066800-C4E8E2CD-41A0-48EE-8000-875AC6EE07B3

P2093

Q35066800-EE188051-E206-4A69-BA96-3CEDA4A0C8CB

P2860

Q35066800-04977A08-D9C6-4887-A812-2472EC0865EC

Q35066800-0CCA6FF5-91E8-41F9-B5AD-78BBDE859AD2

Q35066800-14CE6B2D-B99A-4374-907E-244320DED471

Q35066800-20044884-6574-4678-9B64-4B7170B8B5BE

Q35066800-24189FC2-C2CA-49C1-84E8-9C88534423CA

Q35066800-2537F268-B4B0-45ED-A9A2-8C4A74629397

Q35066800-34C4A79E-96A3-4FDA-9882-1F2EF5C1D612

Q35066800-34FFA786-7058-48FF-A928-0444A9D382E6

Q35066800-366EB2DF-4F70-4CAD-81E2-B4160C7E96F8

Q35066800-3AD52A0F-D8B1-43F1-884F-BC26924D0491

P304

Q35066800-8F23A372-976A-4053-A2AC-5AB239159273

P31

Q35066800-62A5CA6D-5C5C-43B4-BD1D-C8F8AC198C50

P356

Q35066800-F5B7714C-BB9E-42E6-BE79-7643E5F01420

P407

Q35066800-379DC60C-193F-4979-A2F3-8CCFFAFF3C89

P433

Q35066800-6171CC76-0623-4749-9D2A-1DC32C78A4F4

P478

Q35066800-6A758B9C-0150-4592-AE97-68E6505CD910

P577

Q35066800-55E1DA20-CF0A-425F-B460-3513349ABAFA

P698

Q35066800-3EA6AD90-2865-4594-9024-A74E698F194B

P356

PHCO.23.2.173.32095

P1433

Pharmacotherapy

P1476

Angiotensin II receptor blockers in heart failure.

@en

P2093

J Herbert Patterson

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.

Pharmacokinetics of eprosartan in healthy subjects, patients with hypertension, and special populations.

P304

173-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.23.2.173.32095

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12587806

http://www.w3.org/2001/XMLSchema#string